About Lightship
Lightship is a Healthcare company based in El Segundo (United States) founded in 1995 by Samantha Eells and Brian Lovett. Direct-to-patient clinical trial solutions are provided by Lightship. It operates on a Professional Services and HealthTech model. Lightship has raised $205.55 million across 4 funding rounds from investors including McKesson, Khosla Ventures and Brook Porter. The company has 74 employees. Its chief executive, as recorded, is David MacMurchy. Lightship offers products and services including Decentralized Trials, Hybrid Trials, Outreach & Recruitment, Mobile Research Units, and Mobile Nurses. Its focus areas include Clinical Research and Decentralized Trials. Its competitors include Clario, SFJ Pharmaceuticals and N-Power Medicine; 1 of its 3 listed competitors has raised funding.
Company details
Clinical trial services are offered by Lightship, focusing on decentralized and hybrid trials to enhance access and inclusivity. Solutions are designed for biopharmaceutical sponsors, academic institutions, and CROs across the US and UK. Expertise is applied in therapeutic areas like cardiovascular disease, oncology, and rare diseases. Community-based outreach and mobile units are utilized to enroll representative populations. Patient-centered approaches are maintained from trial startup to close-out, ensuring high retention and diversity.
- Headquarters El Segundo, United States
- Employees 74
- Founders Samantha Eells, Brian Lovett
- SectorsHealthcare
- Email••••••••
- Website lightship.com
- Social LinkedIn X Facebook
- Total Equity Funding$205.55M (USD)
in 4 rounds
- Latest Funding Round$135.55M (USD), Series D
Feb 2024
- InvestorsMcKesson
& 5 more
- Employee Count74
Products & Services of Lightship
Lightship offers a comprehensive portfolio of products and services, including Decentralized Trials, Hybrid Trials, Outreach & Recruitment, Mobile Research Units, and Mobile Nurses.
Trials are delivered without geographical limits for inclusivity.
Hybrid studies are conducted with remote and site networks.
Representative populations are enrolled through community-based outreach models.
Community clinic settings are provided for study visits.
Home study visits are conducted by dedicated nurses.
Funding Insights of Lightship
Lightship has successfully raised a total of $205.55M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $135.55 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $205.55M
- Total Rounds 4
- Last Round Series D — $135.55M
- First Round $20M
(Feb 2020)
- Investors Count 6
All 4 funding rounds of Lightship with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $135.55M | Series D | – | – | – |
| Sep 2021 | $40M | Series C | – | Brook Porter, Define Ventures | |
| Apr 2021 | $10M | Series B | – | – | – |
| Feb 2020 | $20M | Series B | – | McKesson Ventures, Define Ventures |
6 investors in total: 4 institutional and 2 angel.
Investors in Lightship
Lightship has secured backing from 6 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include McKesson, Khosla Ventures and Brook Porter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Define Ventures is focused on early-stage health tech investments. | definevc.com | |||
Early-stage startups are funded by this venture capital firm. | 2004 | khoslaventures.com | Menlo Park, United States | |
Investments are directed by McKesson Ventures toward early-stage healthcare startups. | ventures.mckesson.com | San Francisco, United States | ||
Products and services are provided in the healthcare industry. | 1833 | mckesson.com | Irving, United States | |
BP Brook Porter | Partner at G2VP, angel investor, focused on cleantech and sustainability. | unknown_d6d0946a301140d8b | ||
MB Marc Benioff | unknown_eb6b3f82b4f34a3e9 |
Investor details for Lightship
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lightship
16 people are tracked at Lightship (13 in leadership, 3 in team); the tracked headcount is 74.
| Name | Role | Group |
|---|---|---|
Samantha Eells | Co-Founder | Leadership |
Brian Lovett | Co-Founder | Leadership |
David MacMurchy | CEO | Leadership |
Darcy Forman | Chief Operating Officer | Leadership |
Amy J Ford | Senior Director Study Solutions (business Development) | Leadership |
Goran Stanišić | Director of Data Warehousing | Leadership |
Anushka Loomba | Director, Strategic Operations & Chief of Staff | Leadership |
Alon Krashinsky | Co-Founder | Leadership |
Michael Cohen-Wolkowiez | Chief Medical Officer | Leadership |
Sepehr S. | Vice President, Design Solutions | Leadership |
Ellie Holmes | Associate Director Business Development | Leadership |
Michael Shipton | Chief Business Officer (cbo) | Leadership |
Sudhir Waghmare | Vice President of Technology | Leadership |
Taylor Tanner | Senior Manager, Design | Team |
Rebecca Geiger | Senior Manager, Design Solutions | Team |
Bruno D. | Software Development Engineer | Team |
Complete people profiles for Lightship
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lightship
3 dated milestones of Lightship across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Lightship is founded.
- Funding First funding round of $20.0M.
- Funding Latest funding round, Series D, of $135.5M.
Competitors of Lightship
Lightship has 3 listed competitors in our database, 1 of them funded. They include Clario, SFJ Pharmaceuticals and N-Power Medicine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| clario.com | 1972 | Philadelphia, United States | 11 | CRO focused on providing clinical trial supply services for biopharma sector | ||
| sfj-pharma.com | 2008 | Pleasanton, United States | $69.5M | 12 | Specialty pharmaceutical company based on partnering model | |
| npowermedicine.com | 2021 | Redwood, United States | Clinical trial services are provided to support medical research initiatives. |
Detailed competitors of Lightship
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lightship
The website of Lightship (lightship.com) receives about 2.8K visits a month.
- Monthly visits2.8K
▲ 31.6% vs previous month
Websites whose visitors overlap most with Lightship. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lightshiprv.com | 100% | 62.8K | #615,625 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Lightship (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lightship
Complete news archive for Lightship
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lightship
Lightship was founded in 1995 and raised its 1st funding round 25 years after it was founded.
Lightship is headquartered in El Segundo, United States. It is registered at El Segundo, California, United States.
David MacMurchy is the CEO of Lightship, as recorded in our data.
Lightship is a funded company, having raised a total of $205.55M across 4 funding rounds to date. The company's 1st funding round was a Series B of $20M, raised on Feb 2020.
Lightship has 74 employees.
Clinical trial services are offered by Lightship, focusing on decentralized and hybrid trials to enhance access and inclusivity. Solutions are designed for biopharmaceutical sponsors, academic institutions, and CROs across the US and UK. Expertise is applied in therapeutic areas like cardiovascular disease, oncology, and rare diseases. Community-based outreach and mobile units are utilized to enroll representative populations. Patient-centered approaches are maintained from trial startup to close-out, ensuring high retention and diversity.
Lightship's top competitors include SFJ Pharmaceuticals, N-Power Medicine and Clario.
Lightship offers Decentralized Trials, Hybrid Trials, Outreach & Recruitment, Mobile Research Units, and Mobile Nurses.
Lightship has 6 investors. Key investors include McKesson, Khosla Ventures, Brook Porter, Define Ventures, and McKesson Ventures.